Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression

Hepatology

Volumn 27, Issue 5, 1998, Pages 1233-1240

  Saito, Hidetsugu ^a   Ebinuma, Hirotoshi ^a   Takahashi, Masahiko ^a   Kaneko, Fumihiko ^a   Wakabayashi, Kanji ^a   Nakamura, Mitsuyasu ^a   Ishii, Hiromasa ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BLOTTING, WESTERN; BUTYRATES; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENES, P53; HUMANS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031970937     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270508     Document Type: Article

References (19)

1. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sarchez-Tapias JM, Ventura M, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;ii:1004-1006.
2. Colombo R, Kuo G, Choo QL, Donato MF, Ninno ED, Tommasini MA, Dioguardi N, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;ii:1006-1008.
3. Tremolada F, Benvegnu L, Casarin C, Pontisso P, Tagger A, Alberti A. Antibody to hepatitis C virus in hepatocellular carcinoma. Lancet 1990;335:300-301.
4. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, Tsuji T, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991;67:429-433.
5. Matsumata T, Kanematsu T, Takenaka K, Yoshiba Y, Nishizaki T, Sugimachi K. Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma. HEPATOLOGY 1989;9:457-460.
6. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analysis. HEPATOLOGY 1991;14:802-805.
7. Yamasaki S, Hasegawa H, Takayama T, Kosuge T, Shimada K, Yamamoto J. Clinicopathological features of recurrent primary liver cancer in Japan. In: Okuda, K. ed. Primary Liver Cancer in Japan. Tokyo, Japan: Springer-Verlag, 1992:345-351.
8. Ikeda K, Saitoh S, Tsubota A, Arase K, Chayama K, Kanada H, Watanabe G, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993;71:19-25.
9. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, Chang YC, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993;105:488-494.
10. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994;74:2772-2780.
11. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, Takeyoshi M. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroemerology 1995;108:768-775.
12. The Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan: report 11. Acta Hepatol Jpn 1995;36:208-218.
13. Oka H, Yamamoto S, Kuroki T, Harihara S, Marumo T, Kim SR, Monna T, et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 1995;76:743-749.
14. Muto Y, Morikawa H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996;334:1561-1567.
15. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States. New York: Oxford University Press, 1991.
16. Cummings JH. Short-chain fatty acids in the human colon. Gut 1981;22:763-779.
17. Kruh J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 1982;42:65-82.
18. Planchon P, Raux H, Magnien V, Ronco G, Villa P, Crepin M, Brouty-Boye D. New stable butyrate derivatives alter proliferation and differentiation in human mammary cells. Int J Cancer 1991;48:443-449.
19. Saito H, Morizane T, Watanabe T, Kagawa T, Miyaguchi S, Kumagai N, Tsuchiya M. Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC-M and HCC-T. Int J Cancer 1991;48:291-296.